167 related articles for article (PubMed ID: 148902)
1. Fibrinolytic activity in utero and bleeding complications with intrauterine contraceptive devices.
Bonnar J; Kasonde K; Haddon M; Hassanein MK; Allington MJ
Br J Obstet Gynaecol; 1976 Feb; 83(2):160-4. PubMed ID: 148902
[TBL] [Abstract][Full Text] [Related]
2. Fibrinolytic activity in bleeding associated with intrauterine contraceptive devices.
Khanna A; Biswas AK; Dubey B; Khanna AK
Indian J Med Res; 1992 Jun; 96():147-9. PubMed ID: 1512035
[TBL] [Abstract][Full Text] [Related]
3. Production of fibrinolytic enzymes by macrophages on intrauterine contraceptive devices.
Foley ME; Jenkins DM; McNicol GP
Br J Obstet Gynaecol; 1978 Jul; 85(7):551-6. PubMed ID: 678491
[TBL] [Abstract][Full Text] [Related]
4. Fibrinolytic activity of menstrual blood in normal and menorrhagic women and in women wearing the Lippes Loop and the Cu-T (200).
Hefnawi F; Saleh A; Kandil O; El-Sheikha Z; Hassanein M; Askalani H
Int J Gynaecol Obstet; 1979; 16(5):400-7. PubMed ID: 35409
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activators in the endometrium of women using intrauterine contraceptive devices.
Kasonde JM; Bonnar J
Br J Obstet Gynaecol; 1976 Apr; 83(4):315-9. PubMed ID: 1268139
[TBL] [Abstract][Full Text] [Related]
6. The response of endometrial blood vessels to intrauterine contraceptive devices: an electron microscopic study.
Sheppard BL; Bonnar J
Br J Obstet Gynaecol; 1980 Feb; 87(2):143-54. PubMed ID: 7362802
[TBL] [Abstract][Full Text] [Related]
7. The effect of tranexamic acid on measured menstrual loss and endometrial fibrinolytic enzymes in dysfunctional uterine bleeding.
Gleeson NC; Buggy F; Sheppard BL; Bonnar J
Acta Obstet Gynecol Scand; 1994 Mar; 73(3):274-7. PubMed ID: 8122512
[TBL] [Abstract][Full Text] [Related]
8. No increased systemic fibrinolysis in women with heavy menstrual bleeding.
Wiewel-Verschueren S; Knol HM; Lisman T; Bogchelman DH; Kluin-Nelemans JC; van der Zee AG; Mulder AB; Meijer K
J Thromb Haemost; 2014 Sep; 12(9):1488-93. PubMed ID: 24954113
[TBL] [Abstract][Full Text] [Related]
9. The fibrinolytic enzyme system in normal menstruation and excessive uterine bleeding and the effect of tranexamic acid.
Dockeray CJ; Sheppard BL; Daly L; Bonnar J
Eur J Obstet Gynecol Reprod Biol; 1987 Apr; 24(4):309-18. PubMed ID: 2953634
[TBL] [Abstract][Full Text] [Related]
10. [Endouterine fibrinolytic activity in users of intrauterine devices].
Gayán P; Miller ME; Corbalán G; Galán G; Tisné L; Aimuna R; Lynch B; Abarca S; Pasternack S
Rev Chil Obstet Ginecol; 1979; 44(5):237-44. PubMed ID: 262667
[TBL] [Abstract][Full Text] [Related]
11. Fibrinolytic cross-talk: a new mechanism for plasmin formation.
Dejouvencel T; Doeuvre L; Lacroix R; Plawinski L; Dignat-George F; Lijnen HR; Anglés-Cano E
Blood; 2010 Mar; 115(10):2048-56. PubMed ID: 19996088
[TBL] [Abstract][Full Text] [Related]
12. Endometrial fibrinolytic enzymes in women with normal menstruation and dysfunctional uterine bleeding.
Gleeson N; Devitt M; Sheppard BL; Bonnar J
Br J Obstet Gynaecol; 1993 Aug; 100(8):768-71. PubMed ID: 8399019
[TBL] [Abstract][Full Text] [Related]
13. Haemostasis in menstrual endometrium in the presence of an intrauterine device.
Christiaens GC; Sixma JJ; Haspels AA
Br J Obstet Gynaecol; 1981 Aug; 88(8):825-37. PubMed ID: 7260004
[TBL] [Abstract][Full Text] [Related]
14. Endometrial lysosomal enzyme activity in ovulatory dysfunctional uterine bleeding, IUCD users and post-partum women.
Wang IY; Fraser IS; Barsamian SP; Manconi F; Street DJ; Cornillie FJ; Russell P
Mol Hum Reprod; 2000 Mar; 6(3):258-63. PubMed ID: 10694274
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effect of histidine-rich glycoprotein and 6-aminohexanoic acid on plasmin production and fibrinolysis in vitro.
Horne MK; Goad JL; Merryman PK; Cullinane AM
Thromb Res; 2000 Jul; 99(2):179-86. PubMed ID: 10946092
[TBL] [Abstract][Full Text] [Related]
16. Editorial: IUDs and heavy periods.
Br Med J; 1976 Feb; 1(6005):304. PubMed ID: 1247833
[TBL] [Abstract][Full Text] [Related]
17. Management of IUD-associated menorrhagia in female rhesus monkeys (Macaca mulatta).
Barthwal M; Srivastava K
Adv Contracept; 1991 Mar; 7(1):67-76. PubMed ID: 1908176
[TBL] [Abstract][Full Text] [Related]
18. Reduced menstrual blood loss by release of an antifibrinolytic agent from intrauterine contraceptive devices.
Tauber PF; Kloppel A; Goodpasture JC; Burns J; Ludwig H; Zaneveld LJ
Am J Obstet Gynecol; 1981 Jun; 140(3):322-8. PubMed ID: 7246636
[TBL] [Abstract][Full Text] [Related]
19. Comparison between antifibrinolytic and antiprostaglandin treatment in the reduction of increased menstrual blood loss in women with intrauterine contraceptive devices.
Ylikorkala O; Viinikka L
Br J Obstet Gynaecol; 1983 Jan; 90(1):78-83. PubMed ID: 6336951
[TBL] [Abstract][Full Text] [Related]
20. Cyclic changes in endometrial tissue plasminogen activator and plasminogen activator inhibitor type 1 in women with normal menstruation and essential menorrhagia.
Gleeson NC
Am J Obstet Gynecol; 1994 Jul; 171(1):178-83. PubMed ID: 8030696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
